Evidence map›Paper›PMID 40439216›Full record

ArticleJournal of the American Chemical Society2025

A Multi-Threshold Micelle Improves Tumor Accumulation and STING Immunotherapy.

Zachary T Bennett, Animeshasavithri Krishnamurthy, Shuyue Ye, Vijay S Basava, Qiang Feng, Gang Huang, Baran D Sumer, Jinming Gao

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zachary T BennettDepartment of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0001-9994-7939
Animeshasavithri KrishnamurthyDepartment of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0002-3014-9725
Shuyue YeHarold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Vijay S BasavaHarold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Qiang FengDepartment of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0002-3665-3914
Gang HuangHarold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0001-6658-9557
Baran D SumerDepartment of Otolaryngology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Jinming GaoDepartment of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0003-0726-5098

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
Project 3U54CA244719 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GAO, JINMING · 2019 to 2019
$5.2M
Investigating TLR-agonist adjuvancy in STING-activating nanoparticle cancer vaccinesF31CA247152 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BENNETT, ZACHARY · 2021 to 2023
$107k
NCI NIH HHS F31 CA247152NCI NIH HHS P30 CA142543NCI NIH HHS U54 CA244719
6 · The paper itself

Abstract

Stimulator of interferon genes (STING) is a critical innate immune protein that potentiates anticancer immunity. An adjuvanted micelle, PC7A, directly binds to STING and coordinates robust immune signaling after local tumor delivery but is not optimized for intravenous administration. To improve systemic delivery, we engineered a hybrid, STING-activating micelle (HySTING) composed of an immune-stimulating polymer, PEG-

Indexed as

ImmunotherapyMembrane ProteinsMicellesNeoplasmsAnimalsCell Line, TumorHumansMiceSTING ProteinMembrane ProteinsMicellesSTING1 protein, humanSting1 protein, mouseSTING Protein

Identifiers

PMID40439216
PMCPMC13477801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.